Analyst Mike Matson highlighted that the growth story for Boston Scientific depends heavily on its cardiac implant, Watchman. Watchman is a medical device that's effectively designed to reduce the ...

The OPTION trial is a significant study for Boston Scientific as it evaluates the potential market expansion for its left-atrial-appendage-closure (LAAC) device, WATCHMAN, which is projected to ...

The OPTION trial is a significant study for Boston Scientific as it evaluates the potential market expansion for its left-atrial-appendage-closure (LAAC) device, WATCHMAN, which is projected to ...

Warning! GuruFocus has detected 5 Warning Sign with BSX. Analyst Mike Matson highlighted that the growth story for Boston Scientific depends heavily on its cardiac implant, Watchman. Watchman is a ...

The company should continue to benefit from market share gains for some of its products, including Watchman. Our interactive dashboard analysis of the Boston Scientific’s FY 2024Q3 Earnings ...

This growth is driven by strong performances in the ICTx and EP business sectors, and the WATCHMAN franchise. Boston Scientific has also received recent product approvals, including the FARAVIEW ...